Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8854)
All Articles published online
|
Publishing Process of This Article
|
Mar 8, 2017 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ponziani FR, Mangiola F, Binda C, Zocco MA, Siciliano M, Grieco A, Rapaccini GL, Pompili M, Gasbarrini A. Future of liver disease in the era of direct acting antivirals for the treatment of hepatitis C. World J Hepatol 2017; 9(7): 352-367 [PMID: 28321272 DOI: 10.4254/wjh.v9.i7.352] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v9/i7/352.htm |
| Number | Citing Articles |
| 1 |
U. Fedeli. Increasing mortality associated with the more recent epidemic wave of hepatitis C virus infection in Northern Italy. Journal of Viral Hepatitis 2018; 25(8): 996 doi: 10.1111/jvh.12893
|
| 2 |
Valentina Cossiga, Marco Sanduzzi-Zamparelli, Victor Sapena, Maria Guarino, Marcello Dallio, Emanuele Torrisi, Luca Pignata, Alessandro Federico, Federico Salomone, Filomena Morisco. Beneficial Effects of Silybin Treatment After Viral Eradication in Patients With HCV-Related Advanced Chronic Liver Disease: A Pilot Study. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.824879
|
| 3 |
Antoni Sicras-Mainar, Ruth Navarro-Artieda, Marc Sáez-Zafra. Comorbidity, concomitant medication, use of resources and healthcare costs associated with chronic hepatitis C virus carriers in Spain. Gastroenterología y Hepatología (English Edition) 2018; 41(4): 234 doi: 10.1016/j.gastre.2018.04.015
|
| 4 |
Daniel Sepúlveda‐Crespo, Ana Treviño‐Nakoura, José M. Bellón, Amanda Fernández‐Rodríguez, Pablo Ryan, Isidoro Martínez, María A. Jiménez‐Sousa, Salvador Resino. Diagnostic performance of hepatitis C core antigen assay to identify active infections: A systematic review and meta‐analysis. Reviews in Medical Virology 2023; 33(3) doi: 10.1002/rmv.2436
|
| 5 |
Nehal K. Abdel Fattah, Sara M. Shaheen, Osama A. Ahmed, Kadry Elsaeed, Nagwa A. Sabri. Metabolic changes in chronic hepatitis C patients receiving direct acting antivirals. F1000Research 2022; 11: 649 doi: 10.12688/f1000research.109397.1
|
| 6 |
Reham M. Dawood, Mai Abd el-Meguid, Marwa K. Ibrahim, Noha G. Bader El Din, Ahmed Barakat, Khaled El-Wakeel, Mohamed Darwish Ahmed Abd Alla, George Y. Wu, Mostafa K. El Awady. Dysregulation of fibrosis related genes in HCV induced liver disease. Gene 2018; 664: 58 doi: 10.1016/j.gene.2018.04.032
|
| 7 |
Rashmi Tondon, Kristen M. Stashek. Hyperbilirubinemia in a Hepatitis C Virus Patient After Liver Transplantation. AJSP: Reviews and Reports 2018; 23(5): 217 doi: 10.1097/PCR.0000000000000262
|
| 8 |
Hisham A. Ismail, Doaa Ebrahim, Mohamed A. El-Assal, Mai Abozeid, Eman Abdelsameea. Predictive value of hepcidin in patients with chronic hepatitis C infection among Egyptians. Egyptian Liver Journal 2018; 8(1): 12 doi: 10.1097/01.ELX.0000530863.06773.be
|
| 9 |
Viola Knop, Stefan Mauss, Tobias Goeser, Andreas Geier, Tim Zimmermann, Kerstin Herzer, Nils Postel, Mireen Friedrich‐Rust, Wolf Peter Hofmann. Dynamics of liver stiffness by transient elastography in patients with chronic hepatitis C virus infection receiving direct‐acting antiviral therapy—Results from the German Hepatitis C‐Registry. Journal of Viral Hepatitis 2020; 27(7): 690 doi: 10.1111/jvh.13280
|
| 10 |
Francesca Romana Ponziani, Francesco Santopaolo, Massimo Siciliano, Antonio Giulio De Belvis, Annalisa Tortora, Vincenzina Mora, Caterina Fanali, Alisha Morsella, Fulvio Balducci, Giuseppe Vetrugno, Maria Elena D’Alfonso, Andrea Cambieri, Roberto Cauda, Rocco Bellantone, Maurizio Sanguinetti, Maurizio Pompili, Antonio Gasbarrini. Missed linkage to care for patients who screened positive for Hepatitis C in a tertiary care centre: Results of the Telepass project. Journal of Viral Hepatitis 2021; 28(4): 651 doi: 10.1111/jvh.13465
|
| 11 |
Daniel Sepulveda-Crespo, Salvador Resino, Isidoro Martinez. Hepatitis C virus vaccine design: focus on the humoral immune response. Journal of Biomedical Science 2020; 27(1) doi: 10.1186/s12929-020-00669-4
|
| 12 |
A. Erman, A. Sathya, A. Nam, J. M. Bielecki, J. J. Feld, H‐H. Thein, W. W. L. Wong, P. Grootendorst, M. D. Krahn. Estimating chronic hepatitis C prognosis using transient elastography‐based liver stiffness: A systematic review and meta‐analysis. Journal of Viral Hepatitis 2018; 25(5): 502 doi: 10.1111/jvh.12846
|
| 13 |
Sylvia M Brakenhoff, Robert A de Man, Robert J de Knegt, Patrick J E Bindels, Evelien I T de Schepper. Epidemiology and management of hepatitis B and C in primary care in the Netherlands: data from the Rijnmond Primary Care database. Family Practice 2023; 40(1): 83 doi: 10.1093/fampra/cmac070
|
| 14 |
Aparna Vasanthakumar, Justin W. Davis, Manal Abunimeh, Jonas Söderholm, Jiuhong Zha, Emily O. Dumas, Daniel E. Cohen, Jeffrey F. Waring, Martin Lagging, Tatsuo Kanda. Reduced ITPase activity and favorable IL28B genetic variant protect against ribavirin-induced anemia in interferon-free regimens. PLOS ONE 2018; 13(5): e0198296 doi: 10.1371/journal.pone.0198296
|
| 15 |
Kellie Young, Benny Liu, Taft Bhuket, Robert J. Wong. Lower Likelihood of Post-transplant Graft Failure, Death, and Retransplantation in the Era of Direct-Acting Antivirals. Journal of Clinical and Experimental Hepatology 2020; 10(6): 581 doi: 10.1016/j.jceh.2020.02.003
|
| 16 |
Camelia A. Abdel Malak, Tawfeek H. Abelhafez, Ashraf A. Tabll, Mohammad M. Mashaly, Reem El Shenawy, Yasmine S. El-Abd, Maysa H. Shaker, Mostafa K. El-Awady. Neutralizing activity and safety of human monoclonal antibodies against hepatitis C virus. Human Antibodies 2018; 26(3): 127 doi: 10.3233/HAB-170330
|
| 17 |
Masashi Mizokami, Lauren J. Liu, Naoto Fujiyama, Marcus Littman, Jason Yuan, Tomoko Sekiya, Charlotte Hedskog, Leslie J. Ng. Real‐world safety and effectiveness of ledipasvir/sofosbuvir for the treatment of chronic hepatitis C virus genotype 1 in Japan. Journal of Viral Hepatitis 2021; 28(1): 129 doi: 10.1111/jvh.13395
|
| 18 |
Kellie Young, Benny Liu, Taft Bhuket, Robert G. Gish, Robert J. Wong. Improved liver transplant waitlist mortality and lower risk of disease progression among chronic hepatitis C patients awaiting liver transplantation after the introduction of direct‐acting antiviral therapies in the United States. Journal of Viral Hepatitis 2019; 26(3): 350 doi: 10.1111/jvh.13039
|
| 19 |
T. Medeiros, N. F. Rosário, G. N. Saraiva, T. G. Andrade, A. A. Silva, J. R. Almeida. Renal safety after one year of sofosbuvir‐based therapy for chronic hepatitis C: A Brazilian “real‐life” study. Journal of Clinical Pharmacy and Therapeutics 2018; 43(5): 707 doi: 10.1111/jcpt.12697
|
| 20 |
Frederico Costa, Bertram Wiedenmann, Christoph Roderburg, Raphael Mohr, Ghassan K. Abou‐Alfa. Systemic treatment in patients with Child–Pugh B liver dysfunction and advanced hepatocellular carcinoma. Cancer Medicine 2023; 12(13): 13978 doi: 10.1002/cam4.6033
|
| 21 |
Francesca Romana Ponziani, Luca Miele, Annalisa Tortora, Manuele Furnari, Giorgia Bodini, Maurizio Pompili, Antonio Gasbarrini, Edoardo Giovanni Giannini. Treatment of early stage chronic hepatitis C virus infection. Expert Review of Clinical Pharmacology 2018; 11(5): 519 doi: 10.1080/17512433.2018.1447923
|
| 22 |
Maliha Naseer, Harleen Chela, Alhareth AlJuboori. Viral Hepatitis: Chronic Hepatitis C. 2019; : 25 doi: 10.1007/978-3-030-03757-4_2
|
| 23 |
Daniel Sepulveda-Crespo, Salvador Resino, Isidoro Martinez. Innate Immune Response against Hepatitis C Virus: Targets for Vaccine Adjuvants. Vaccines 2020; 8(2): 313 doi: 10.3390/vaccines8020313
|
| 24 |
Melisa Dirchwolf, Sebastián Marciano, Diego H. Giunta, Maria L. Posadas‐Martínez, Scott W. Biggins, Andrés E. Ruf. Trends in liver transplantation for hepatitis C in a country with reduced access to direct‐acting antiviral agents. Clinical Transplantation 2018; 32(4) doi: 10.1111/ctr.13230
|
| 25 |
Karoly Toth, Ann E. Tollefson, Jacqueline F. Spencer, Baoling Ying, William S.M. Wold. Combination therapy with brincidofovir and valganciclovir against species C adenovirus infection in the immunosuppressed Syrian hamster model allows for substantial reduction of dose for both compounds. Antiviral Research 2017; 146: 121 doi: 10.1016/j.antiviral.2017.08.002
|
| 26 |
Alejandra Pérez-García, Aitziber Aguinaga, Ana Navascués, Jesús Castilla, Carmen Ezpeleta. Hepatitis C core antigen: Diagnosis and monitoring of patients infected with hepatitis C virus. International Journal of Infectious Diseases 2019; 89: 131 doi: 10.1016/j.ijid.2019.09.022
|
| 27 |
G Ireland, R Simmons, M Hickman, M Ramsay, C Sabin, S Mandal. Monitoring liver transplant rates in persons diagnosed with hepatitis C: a data linkage study, England 2008 to 2017.
Eurosurveillance 2019; 24(41) doi: 10.2807/1560-7917.ES.2019.24.41.1900176
|
| 28 |
Dan C. S. Im, Susheel Reddy, Claudia Hawkins, Shannon Galvin. Characteristics and Specialist Linkage to Care of Patients Diagnosed With Chronic Hepatitis C Across Different Settings in an Urban Academic Hospital: Implications for Improving Diagnosis and Linkage to Care. Frontiers in Microbiology 2021; 12 doi: 10.3389/fmicb.2021.576357
|
| 29 |
David E. Bloom, Alexander Khoury, V. Srinivasan, Dario Ummarino. Estimating the net value of treating hepatitis C virus using sofosbuvir-velpatasvir in India. PLOS ONE 2021; 16(7): e0252764 doi: 10.1371/journal.pone.0252764
|
| 30 |
Paul Kubes, Craig Jenne. Immune Responses in the Liver. Annual Review of Immunology 2018; 36(1): 247 doi: 10.1146/annurev-immunol-051116-052415
|
| 31 |
Maria Janda, Kari A. Mergenhagen. The Effect of Psychosocial Factors on Success Rates of Hepatitis C Treatment. Psychosomatics 2017; 58(6): 624 doi: 10.1016/j.psym.2017.07.003
|
| 32 |
Erick Joan Vidal-Alcántara, Vicente Mas, María Belén Yélamos, Julián Gómez, Rafael Amigot-Sánchez, Salvador Resino, Isidoro Martinez. Production and characterization of monoclonal antibodies for the detection of the hepatitis C core antigen. Frontiers in Molecular Biosciences 2023; 10 doi: 10.3389/fmolb.2023.1225553
|
| 33 |
Gastón J. Piñeiro, Jordi Rovira, Fritz Diekmann, Nuria Esforzado. Reply. Liver Transplantation 2020; 26(6): 847 doi: 10.1002/lt.25761
|
| 34 |
Luciana D. Silva, Tatiana Bering, Gifone A. Rocha. The impact of nutrition on quality of life of patients with hepatitis C. Current Opinion in Clinical Nutrition & Metabolic Care 2017; 20(5): 420 doi: 10.1097/MCO.0000000000000396
|
| 35 |
Léonie Petitclerc, Guillaume Gilbert, Bich N. Nguyen, An Tang. Liver Fibrosis Quantification by Magnetic Resonance Imaging. Topics in Magnetic Resonance Imaging 2017; 26(6): 229 doi: 10.1097/RMR.0000000000000149
|
| 36 |
Fardad Ejtehadi, Paymun Farahvashi, Alireza Shamsaeefar, Ramin Niknam, Gholam Reza Sivandzadeh, Ladan Aminlari, Nasrin Motazedian, Kourosh Kazemi, Hamed Nikoupour, Saman Nikeghbalian, Hesameddin Eghlimi, Alireza Taghavi, Mohammadreza Fattahi, Kamran Bagheri Lankarani, Seyyed Ali Malek-Hosseini. Clinical Course and Outcome of Liver Transplantation in Patients with Hepatitis C in Iran. Hepatitis Monthly 2021; 21(3) doi: 10.5812/hepatmon.108405
|
| 37 |
Valentina Pecoraro, Rita Banzi, Elisabetta Cariani, Johanna Chester, Erica Villa, Roberto D'Amico, Vittorio Bertele', Tommaso Trenti. New Direct-Acting Antivirals for the Treatment of Patients With Hepatitis C Virus Infection: A Systematic Review of Randomized Controlled Trials. Journal of Clinical and Experimental Hepatology 2019; 9(4): 522 doi: 10.1016/j.jceh.2018.07.004
|
| 38 |
Leonardo Stella, Francesco Santopaolo, Antonio Gasbarrini, Maurizio Pompili, Francesca Romana Ponziani. Viral hepatitis and hepatocellular carcinoma: From molecular pathways to the role of clinical surveillance and antiviral treatment. World Journal of Gastroenterology 2022; 28(21): 2251-2281 doi: 10.3748/wjg.v28.i21.2251
|
| 39 |
Heba Omar, Mohamed Said, Rasha Eletreby, Mai Mehrez, Mohamed Bassam, Zeinab Abdellatif, Adel Hosny, Sherif Megawer, Mona El Amir, Ayman Yosry. Longitudinal assessment of hepatic fibrosis in responders to direct‐acting antivirals for recurrent hepatitis C after liver transplantation using noninvasive methods. Clinical Transplantation 2018; 32(8) doi: 10.1111/ctr.13334
|
| 40 |
Turabian Jose L. A Narrative Review of Natural History of Diseases and Continuity of Care in Family Medicine. Archives of Community Medicine and Public Health 2017; : 041 doi: 10.17352/2455-5479.000023
|
| 41 |
Felice Nava, Alberto Chiesa, Giovanni Strepparola, Giuseppe Pennisi, Rossano Vitali, Lucia Trevisi, Alfio Lucchini. The earlier the better. The cost of health services in treating PWIDs with chronic hepatitis C: Results from a non-interventional study. MISSION 2020; (54) doi: 10.3280/mis54-2020oa10583
|
| 42 |
Maurizio Sessa, Francesca Futura Bernardi, Andrea Vitale, Beniamino Schiavone, Giulia Gritti, Annamaria Mascolo, Michele Bertini, Cristina Scavone, Liberata Sportiello, Francesco Rossi, Annalisa Capuano. Adverse drug reactions during hepatitis C treatment with direct-acting antivirals: The role of medication errors, their impact on treatment discontinuation and their preventability. New insights from the Campania Region (Italy) spontaneous reporting syste. Journal of Clinical Pharmacy and Therapeutics 2018; 43(6): 867 doi: 10.1111/jcpt.12744
|
| 43 |
Antoni Sicras-Mainar, Ruth Navarro-Artieda, Marc Sáez-Zafra. Comorbilidad, medicación concomitante, uso de recursos y costes sanitarios asociados a los pacientes portadores del virus de la hepatitis C crónica en España. Gastroenterología y Hepatología 2018; 41(4): 234 doi: 10.1016/j.gastrohep.2017.11.008
|
| 44 |
Chao He, Xiaojuan Liu, Wei Peng, Chuan Li, Tian-fu Wen. Evaluation the efficacy and safety of simultaneous splenectomy in liver transplantation patients. Medicine 2018; 97(10): e0087 doi: 10.1097/MD.0000000000010087
|
| 45 |
Caroline Schmidbauer, Michael Schwarz, Angelika Schütz, Raphael Schubert, Cornelia Schwanke, Enisa Gutic, Roxana Pirker, Tobias Lang, Thomas Reiberger, Hans Haltmayer, Michael Gschwantler, Giordano Madeddu. Directly observed therapy at opioid substitution facilities using sofosbuvir/velpatasvir results in excellent SVR12 rates in PWIDs at high risk for non-adherence to DAA therapy. PLOS ONE 2021; 16(6): e0252274 doi: 10.1371/journal.pone.0252274
|